Neoadjuvant Cisplatin-Methotrexate Chemotherapy for Invasive Bladder Cancer – Nordic Cystectomy Trial 2

By Sherif Amir   Rintala Erkki   Mestad Oddvar   Nilsson Jonas   Holmberg Lars   Nilsson Sten   Malmström Per-Uno  

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 6, 2002-12 ,pp. : 419-425

Informa Healthcare

Access to resources Recommend Favorite

The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer

By Kim Philip   Kent Matthew   Zhao Philip   Sfakianos John   Bajorin Dean   Bochner Bernard   Dalbagni Guido  

World Journal of Urology, Vol. 32, Iss. 2, 2014-04 ,pp. : 453-459

Springer Publishing Company

Access to resources Recommend Favorite

S-phase fraction in superficial urothelial carcinoma of the bladder

By Falkman Karin   Tribukait Bernhard   Nyman Claes   Larsson Per   Norming Ulf  

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 4, 2004-09 ,pp. : 278-284

Informa Healthcare

Access to resources Recommend Favorite

Neoadjuvant chemotherapy for bladder cancer

By Black Peter   Brown Gordon   Grossman H.   Dinney Colin  

World Journal of Urology, Vol. 24, Iss. 5, 2006-11 ,pp. : 531-542

Springer Publishing Company

Access to resources Recommend Favorite

Metaphase cytogenetics and DNA flow cytometry with analysis of S-phase fraction in prostate cancer: influence on prognosis

By Bratt O.   Anderson H.   Bak-Jensen E.   Baldetorp B.   Lundgren R.  

Urology, Vol. 47, Iss. 2, 1996-02 ,pp. : 218-224

Elsevier

Access to resources Recommend Favorite